Literature DB >> 12456077

Vitamin E binding protein afamin protects neuronal cells in vitro.

M Heiser1, B Hutter-Paier, L Jerkovic, R Pfragner, M Windisch, M Becker-André, H Dieplinger.   

Abstract

Afamin, an 87 kDa human plasma glycoprotein with specific binding properties for vitamin E (alpha-tocopherol) was recently characterized (Jerkovic, 1997; Vögele, 1999). In the present study the in vitro effects on neuronal cells of native human Afamin, of Afamin pre-loaded with vitamin E (Afamin+), and of vitamin E were investigated. Isolated cortical chicken neurons were maintained either under apoptosis-inducing low serum conditions or exposed to oxidative stress by the addition of H2O2 or beta-amyloid peptide(25-35). Afamin and vitamin E synergistically enhance the survival of cortical neurons under apoptotic conditions. Furthermore, Afamin alone protects cortical neurons from cell death in both experimental settings. Therefore, the plasma glycoprotein Afamin apparently displays a neuroprotective activity not only by virtue of binding and transporting vitamin E but also on its own.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456077     DOI: 10.1007/978-3-7091-6139-5_32

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  14 in total

1.  Afamin is synthesized by cerebrovascular endothelial cells and mediates alpha-tocopherol transport across an in vitro model of the blood-brain barrier.

Authors:  Ingrid Kratzer; Eva Bernhart; Andrea Wintersperger; Astrid Hammer; Sabine Waltl; Ernst Malle; Günther Sperk; Georg Wietzorrek; Hans Dieplinger; Wolfgang Sattler
Journal:  J Neurochem       Date:  2008-11-27       Impact factor: 5.372

2.  Identification of proteins secreted into the medium by human lymphocytes irradiated in vitro with or without adaptive environments.

Authors:  Kanokporn Noy Rithidech; Xianyin Lai; Louise Honikel; Paiboon Reungpatthanaphong; Frank A Witzmann
Journal:  Health Phys       Date:  2012-01       Impact factor: 1.316

3.  Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairment.

Authors:  Wojciech Rozek; Jayme Horning; James Anderson; Pawel Ciborowski
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

4.  The Aging Features of Thyrotoxicosis Mice: Malnutrition, Immunosenescence and Lipotoxicity.

Authors:  Qin Feng; Wenkai Xia; Guoxin Dai; Jingang Lv; Jian Yang; Deshan Liu; Guimin Zhang
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

5.  Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease.

Authors:  Gurudutt Pendyala; Sunia A Trauger; Gary Siuzdak; Howard S Fox
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

6.  Alterations in the aqueous humor proteome in patients with Fuchs endothelial corneal dystrophy.

Authors:  Matthew R Richardson; Zaneer M Segu; Marianne O Price; Xianyin Lai; Frank A Witzmann; Yehia Mechref; Mervin C Yoder; Francis W Price
Journal:  Mol Vis       Date:  2010-11-11       Impact factor: 2.367

7.  Alterations in the aqueous humor proteome in patients with a glaucoma shunt device.

Authors:  Arundhati Anshu; Marianne O Price; Matthew R Richardson; Zaneer M Segu; Xianyin Lai; Mervin C Yoder; Francis W Price
Journal:  Mol Vis       Date:  2011-07-14       Impact factor: 2.367

8.  Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome.

Authors:  Angela Köninger; Philippos Edimiris; Laura Koch; Antje Enekwe; Claudia Lamina; Sabine Kasimir-Bauer; Rainer Kimmig; Hans Dieplinger
Journal:  Endocr Connect       Date:  2014-06-13       Impact factor: 3.335

9.  Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally.

Authors:  Angela Köninger; Antonella Iannaccone; Ensar Hajder; Mirjam Frank; Boerge Schmidt; Ekkehard Schleussner; Rainer Kimmig; Alexandra Gellhaus; Hans Dieplinger
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

10.  Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study.

Authors:  Angela Köninger; Annette Mathan; Pawel Mach; Mirjam Frank; Boerge Schmidt; Ekkehard Schleussner; Rainer Kimmig; Alexandra Gellhaus; Hans Dieplinger
Journal:  Reprod Biol Endocrinol       Date:  2018-03-27       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.